About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,584 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,584 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 801-820 of 6,584 trials

RecruitingZanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell LymphomaFor patients who met the inclusion criteria, treatment regimens were administered: Rituximab 375 mg/m², intravenously, once weekly for 4 weeks.NCT07270835·Suzhou, Jiangsu UnknownA Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's LymphomaThis is a single-arm, open label, dose escalation, phase I study of C-CAR039 in adults with relapsed/refractory B-cell Non-Hodgkin's Lymphoma.NCT04693676·Hangzhou, Zhejiang RecruitingPRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)The aim of this prospective observational cohort study is to investigate the pathophysiological mechanisms behind and risk of pre-eclampsia in women pregnant after fertility…NCT07263490·Copenhagen and 5 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

TerminatedStudy of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell LymphomaThis study has two phases, a dose escalation phase and a dose expansion phase.NCT01402440·Duarte, California and 23 others

TerminatedStudy of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) PatientsRevlimid is a potent immunomodulatory analogue without the teratogenic effects, which has direct anti-tumor effects, anti-angiogenic and both anti-inflammatory and T-cell…NCT01036399·Bologna

CompletedCombination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerRATIONALE: Giving chemotherapy drugs and total-body irradiation before a donor stem cell helps stop the growth of cancer or abnormal cells.NCT00003816·Buffalo, New York

UnknownValidation of the Dutch Translation of the Tobacco, Alcohol, Prescription Medication and Other Substances (TAPS)-ToolThe aim of the study is to investigate the reliability and validity of the Dutch version of the TAPS-tool.NCT05273021·Boekel, North Brabant and 2 others

UnknownSafety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's LymphomaThe purpose of this study is to enable retreatment with Iodine-131 Anti-B1 Antibody therapy for patients with non-Hodgkin's lymphoma (NHL) who previously responded (PR, CCR, or…NCT00022893·Palo Alto, California and 4 others

UnknownGo-CHOP as the Frontline Therapy for PTCLThis is a phase 2 Study to investigate the safety, tolerability, and anti-tumor activity of golidocitinib in Combination with CHOP as the front-line Treatment for Participants…NCT05963347·Zhengzhou, Henan

Active not recruitingDoxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin LymphomaThis phase II trial evaluates how well AVD (doxorubicin, vinblastine, dacarbazine) in combination with brentuximab vedotin and nivolumab work in treating patients with stage I-II…NCT03233347·Duarte, California and 8 others

SuspendedBL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaRATIONALE: BL22 immunotoxin can locate tumor cells and kill them without harming normal cells.NCT00077493·Bethesda, Maryland

UnknownA Single-cell Transcriptome Study in Patients With Non-Hodgkin's LymphomaUsing single-cell RNA sequencing, this study will explore the heterogeneity of lymphoma inside and outside the lymph node, identify tumor specific molecular markers and cell…NCT04434833·Shanghai

RecruitingEpcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)The purpose of this study is to assess if an investigational treatment of Epcoritamab will be beneficial for patients with Marginal Zone Lymphoma (MZL).NCT06796998·Miami, Florida

CompletedEvaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous TransplantationThe study is to determine if NHL patients mobilized with G-CSF (10 µg/kg/day \[GRAN® only\]) plus 0.24 mg/kg/day of plerixafor are more likely to achieve a target number of ≥5 ×…NCT01767714·Beijing and 15 others

WithdrawnRituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00003663·Newport Beach, California and 2 others

RecruitingClinical Study of OR for Second-line Treatment of Refractory MZLThe goal of this clinical trial is to test the overall response rate of Orelabrutinib combined with rituximab (OR regimen) for second-line treatment of relapsed/refractory…NCT06134284·Hangzhou, Zhejiang and 2 others

CompletedFludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or LymphomaRATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophosphamide, before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells.NCT00006252·La Jolla, California and 18 others

CompletedTrial of Haploidentical Stem Cell Transplantation for Haematological CancersThis trial investigates stem cell transplants from partially mismatched donors in patients with blood and bone marrow cancers.NCT01597219·Birmingham and 11 others

UnknownSubcutaneous Sterile Water Injection for Relief of Low Back PainTo compare the effect of subcutenous sterile water injection technique with the subcutaneous saline injection technique in the degree and duration of low back pain-relieving…NCT02813330

CompletedBrain Exercise and Addiction TrialHeavy cannabis use is associated with substantive learning and memory impairments and elevated risk of psychopathology.NCT04902092·Melbourne, Victoria

PreviousPage 41 of 330Next